The Form 4 filing, a public report of insider stock activity, was filed on November 12, 2026. It covers a November 10 trade by Richard Pulik, Roivant Sciences Ltd.'s chief financial officer, or CFO.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-10 |
| Date of Latest Transaction | 2026-11-10 |
| Buy/Sell | sell |
| Transaction Count | 1 |
| Shares Transacted | 125,000 |
| Price | $41.20 |
| Total Transaction Value | $5,150,000.00 |
| Insider | |
| Ticker Symbol | ROIV |
| Company | Roivant Sciences Ltd. |
| Insider Name | Pulik Richard |
| Insider Title | CFO |
| Sector - Industry | Healthcare - Biotechnology |
| Holdings | |
| Total Shares Owned After Transaction | 269,681 |
| Position Size Change | 31.67% |
| Filing | |
| Filing Date | 2026-11-12 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
This was a sale of ROIV shares, reported under transaction code S. The transaction information also suggests a link to an exercise or conversion, which can provide an insider with shares.
What was the average price of the transaction?
The average sale price was $41.20 per share.
How did this transaction affect the insider's holdings?
Richard Pulik sold 125,000 shares and reported owning 269,681 shares afterward. The shares sold made up 31.67% of his reported holdings before the sale.
What's the total transaction value?
The total transaction value was $5,150,000.00 for one reported sale.
Are there any special circumstances around this transaction?
The available details suggest a link to an exercise or conversion involving the same number of shares in the same filing. An exercise can involve using a stock option, a right to buy shares. A conversion can turn another type of investment into shares.
The related exercise or conversion transaction row and the filing's footnote text were unavailable. The matching share count leaves the dates, types of shares, and accounts for the two steps unconfirmed. Whether the exact shares received were sold is also unknown.
For research purposes only; not investment advice.